WHENMarch 29, 2014 @ 8:00am - 5:00pm
WHERE
INFO
REGISTER

SABPA Science & Technology Forum XII: The Promising Future of Clinical Development in San Diego

 

Date: 8:30am – 1:00pm, March 29, 2014 (Saturday), breakfast and lunch will be provided.

Location: Institute of Americas, UCSD (directions available at https://www.sabpa.org/images/instAmericas.jpg)

Registration: https://www.123signup.com/register?id=ddpvm, $20 for online registration, $10 for students and post-docs, $40 for on-site registration

 

Online registration ends March 27, 2014  

 

San Diego is a vibrant and successful biotech hub consisting of over 400 biotech/pharma companies and a cluster of world-renowned academic research institutions. From Rituximab, a biologic drug approved over a decade ago to the most recent Crizotinib, a small molecule drug, biotech/pharma companies in San Diego are continuing to produce innovative medicines to treat patients with cancer, diabetes, inflammation and other diseases. While strong in its biotech/pharma R&D functions, San Diego is emerging as a center for clinical trials, an essential part of the drug development process. Furthermore, as clinical trials have become increasingly global oriented, San Diego is poised to play a leadership role in establishing partnership and conducting clinical collaborations globally, particularly with Asian Pacific countries.

 

At the SABPA Science & Technology Forum XII, we bring together leaders from both the academia and the pharma/biotech industry to discuss how to move drugs quickly and efficiently through clinical studies to patients. Speakers from the UCSD Moores cancer center and pharma companies will share their visions and efforts in strengthening the clinical trial capability in San Diego to better serve the need of the local biotech/pharma community and to make San Diego a designated center for personalized cancer therapy. Speakers from leading clinical centers in China will also provide their insights into how biotech/pharma companies in San Diego can leverage the emerging and rapidly growing clinical market in China to accelerate the clinical development processes.

Speakers

Scott M. Lippman, M.D.

Professor of Medicine,Director, UCSD Moores Cancer Center

 

Razelle Kurzrock, M.D.

Professor of Medicine, Director,Division of Clinical Science, UCSD Moores Cancer Center

 

Andreas Koester, M.D., Ph.D.

VP, Clinical Trial Innovation & External Alliances, Janssen, Pharmaceutical Companies of Johnson & Johnson

 

Steffan Ho, M.D., Ph.D.

Senior Director, Early Development and Translational Oncology, Pfizer

 

Eric Groves, M.D., Ph.D.

VP, Global Strategic Drug Development Innovation at Quintiles

 

Dan Zhang, Ph.D.

CEO, Fountain Medical Development Ltd.

 

Ida Deichaite, Ph.D.

Director, Industry Relations, UCSD Moores Cancer Center

 

8:00    Registration & Breakfast

8:30    Opening Remarks

8:35    Chairperson of Session 1

 

8:40    Scott Lippamn, M.D.

Professor of Medicine, Director, UCSD Moores Cancer Center

 

9:15    Andreas Koester, MD., Ph.D.

VP, Clinical Trial Innovation & External Alliance. Janssen, Pharmaceutical Companies of Johnson & Johnson

 

9:45    Steffan Ho, M.D., Ph.D.

Senior Director, Early Development and Translational Oncology, Pfizer

 

10:15  Refreshment Break, Exhibit & Newtworking

 

10:40  Chairperson of Session 2

 

10:45  Eric Groves, M.D., Ph.D.

VP, Global Strategic Drug Development Innovation at Quntiles

 

11:15  Dan Zhang, Ph.D.

CEO, Fountain Medical Development Ltd.

 

11:45  Panel Discussion: Strengthen Clinical Development in San Diego

Moderator: Ida Deichaite, Ph.D., Director, Industry Relations, UCSD Moores Cancer Center

Panelists:

Razelle Kurzrock, M.D., Professor of Medicine, Director, Division of Clinical Science, UCSD Moores Cancer Center

Jason Sicklick, M.D., Ph.D. Attending Surgeon, Assistant Professor of Surgery, Division of Surgical Oncology, Moores Cancer Center

12:45   Closing Remarks

 

12:50   Lunch & Network